Dialysis Facility Report for FY (FY) 2017
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE
Dialysis Facility Report for Fiscal Year (FY) 2017
*Purpose
of the Report
The Dialysis Facility Report (DFR) for FY 2017 is provided as a resource for characterizing selected aspects of clinical
experience at this facility relative to other caregivers in this state, ESRD Network, and across the United States. Since
these data could be useful in quality improvement and assurance activities, each state’s surveying agency may utilize this
report as a resource during the FY 2017 survey and certification process.
*This
e
This report has been prepared for this facility by the University of Michigan Kidney Epidemiology and Cost Center
(UM-KECC) with funding from the Centers for Medicare & Medicaid Services (CMS) and is based primarily on data
reported in CROWNWeb, Medicare claims and data collected for CMS. It is the twenty-first in a series of annual
reports. This is one of 6,783 reports that have been distributed to ESRD providers in the U.S.
DFR includes data specific to CCN(s): 999999
Overview: This report includes summaries of patient characteristics, treatment patterns, and patient outcomes for
pl
chronic dialysis patients who were treated in this facility between January 2012 and December 2015. Mortality,
hospitalization, and transplantation statistics are reported for a three- or four-year period. Regional and national averages
are included to allow for comparisons. Several of the summaries of patient mortality, hospitalization, and transplantation
are adjusted to account for the characteristics of the patient mix at this facility, such as age, sex and diabetes as a cause
of ESRD. Unless otherwise specified, data refer to hemodialysis (HD) and peritoneal dialysis (PD) patients combined.
Sa
m
Selected highlights from this report are given on pages 2 and 3. For a complete description of the methods used to
calculate the statistics in this report, please see the Guide to the Dialysis Facility Reports for FY 2017. The Guide may be
downloaded from the methodology section of the Dialysis Data website at www.DialysisData.org.
What's New This Year: As part of a continuing effort to improve the quality and relevance of this report for your
facility, the DFR for FY 2017 has been reorganized by measure area. Summaries for All Dialysis Patients Treated as of
December 31st of Each Year (former Table 10) and Characteristics of New Dialysis Patients (former Table 9) may now
be found at the beginning of the Report. The following NEW tables include measures previously reported in Table 6
(Facility Modality, Anemia Management, and Dialysis Adequacy for Medicare Dialysis Patients) and Table 14
(CROWNWeb Clinical Data): Table 8: Anemia Management; Table 9: Dialysis Adequacy and Table 10: Mineral
Metabolism. Vascular access type and access-related infection summaries have been combined and in the new Table 11.
Most recent patient placement information and Medicare eligibility summaries reported on the Annual Facility Survey;
and basic survey information formally reported in Tables 13 and 15, respectively, may now be found in the new Table
13: Facility Information.
*How
to Submit Comments
Between July 15, 2016 and August 15, 2016, facilities may submit comments to their state surveyor or UM-KECC by
visiting www.DialysisData.org, logging on to view their report, and clicking on the Comments & Inquiries tab.
Questions or comments after the comment period is over may be submitted to us directly at DialysisData@umich.edu or
1-855-764-2885.
(1) State Surveyor: Dialysis facilities may submit comments on the DFR for their state's surveyors. State
surveyor(s) will receive a copy of their DFR with the comments they submitted in September 2016.
(2) UM-KECC: Submit questions or suggestions to improve the DFR to UM-KECC. These comments will not
be shared with CMS or your state surveyor.
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
---
Produced by The University of Michigan Kidney Epidemiology and Cost Center (July 2016)
1/22
Dialysis Facility Report for FY (FY) 2017
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE
*Facility
Highlights
Patient Characteristics (Tables 1 and 2):
• Among the 34 patients with Medical Evidence Forms (CMS-2728) indicating treatment at this facility during
2015:
• 44% of these patients were not under the care of a nephrologist before starting dialysis, compared to 21% in
your State, 23% in your Network, and 23% nationally.
• 100% of these patients were informed of their transplant options, compared to 88% in your State, 88% in your
Network, and 87% nationally.
• Among the patients treated at this facility on December 31, 2015, 7% were treated in a nursing home during the
year, compared to 15% nationally.
pl
e
Standardized Mortality Ratio (SMR) (Table 3):
• At this facility, the 2012-2015 SMR is 0.85, which is 15% fewer deaths than expected at this facility. Among all
U.S. facilities, 28% of facilities had a four-year SMR lower than 0.85. This difference is not statistically
significant (p>=0.05), so this lower mortality could plausibly be just a chance occurrence. The 2012-2015 SMR
of observed to expected deaths is 0.97 and 0.97 for your State and Network, respectively.
• At this facility, the 2012-2014 first-year SMR of observed to expected deaths is 0.90, which is 10% fewer deaths
than expected at this facility. Among all U.S. facilities, 46% of facilities had a first-year SMR lower than 0.90.
This difference is not statistically significant (p>=0.05), so this lower mortality could plausibly be just a chance
occurrence. The first-year SMR (2012-2014) of observed to expected deaths is 1.00 and 1.02 for your State and
Network, respectively.
Sa
m
Hospitalizations and Readmissions (Table 4):
• The 2012-2015 SHR (Admissions) at this facility is 0.78, which is 22% fewer admissions hospitalized than
expected. This difference is not statistically significant (p>=0.05), so this lower hospitalization could plausibly be
just a chance occurrence. The 2012-2015 SHR (Admissions) for your State and Network is 0.96 and 0.99,
respectively.
• The 2015 SRR at this facility is 1.15, which is 15% more admissions than expected. This difference is not
statistically significant (p>=0.05), so the higher number of readmissions could plausibly be just a chance
occurrence. The 2015 SRR for your State and Network is 1.04 and 1.05, respectively.
Infection (Tables 4 and 11):
• The percentage of Medicare dialysis patients at this facility hospitalized with septicemia during 2012-2015 was
13.9%, compared to 11.7% in your State, 11.9% in your Network, and 10.9% nationally.
• The rate of PD catheter-related infection was 8.5 per 100 PD patient-months, compared to 2.2 in your State, 2.3
in your Network, and 2.5 nationally.
Transplantation (Table 5):
• Of the patients under age 70 treated at this facility during 2012-2015 who had not previously received a
transplant, 9% were transplanted annually, while a rate of 7% would be expected for these patients.
• The 2012-2015 Standardized 1 st Transplantation Ratio (STR) of observed to expected number of patients
transplanted for this facility is 1.29, which is 29% higher than expected for this facility. This difference is not
statistically significant (p>=0.05) and could plausibly be due to random chance. The 2012-2015 STR for your
State and Network is 0.97 and 0.82, respectively.
Transplant Waitlist (Table 6):
• Among the 143 dialysis patients under age 70 treated at this facility on December 31, 2015, 43% were on the
kidney transplant waitlist, compared to 23% nationally. This difference is statistically significant (p<0.05) and is
unlikely to be due to random chance. The percentage of patients on the kidney transplant waitlist on December
31, 2015, in your State and Network is 31% and 26%, respectively.
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
---
Produced by The University of Michigan Kidney Epidemiology and Cost Center (July 2016)
2/22
Dialysis Facility Report for FY (FY) 2017
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE
Influenza Vaccination (Table 7):
• Among the 106 Medicare dialysis patients treated at this facility on December 31, 2015, 75% were vaccinated
between August 1 and December 31, 2015 compared to 73% nationally. This difference is not statistically
significant (p>=0.05) and is plausibly due to random chance. The percentage of patients vaccinated in your
State, Network, and Nation is 73%, 72%, and 73%, respectively.
Anemia Management (Table 8):
• Among the 87 HD patients in this facility included in the analysis in 2015, 13% had a hemoglobin value below
10 g/dL, compared to 12% in your State, 13% in your Network, and 16% nationally.
• Among the 18 PD patients in this facility included in the analysis in 2015, 28% had a hemoglobin value below 10
g/dL, compared to 23% in your State, 23% in your Network, and 26% nationally.
e
Dialysis Adequacy (Table 9):
• In 2015, 99% of eligible HD patient-months had a Kt/V >=1.2, compared to 96% in your State, 96% in your
Network, and 95% nationally.
• In 2015, 21% of eligible PD patient-months had a Kt/V >=1.7, compared to 88% in your State, 86% in your
Network, and 87% nationally.
pl
Mineral Metabolism (Table 10):
• In 2015, 18% of eligible patient-months had a serum phosphorus value >7.0 mg/dL, compared to 11% in your
State, 10% in your Network, and 12% nationally.
• In 2015, 2% of eligible patient-months had calcium uncorrected value >10.2 mg/dL, compared to 3% in your
State, 3% in your Network, and 3% nationally.
Sa
m
Vascular Access (Table 11):
• At this facility in 2015, 5% of incident patients had arteriovenous (AV) fistulae in place, compared to 23% in
your State, 21% in your Network, and 22% nationally.
• Of the prevalent patients receiving hemodialysis treatment at this facility in 2015, 21% had a catheter which had
been in place for at least 90 days as their only vascular access, compared to 10% in your State, 10% in your
Network, and 10% nationally.
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
---
Produced by The University of Michigan Kidney Epidemiology and Cost Center (July 2016)
3/22
Dialysis Facility Report for FY (FY) 2017
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE
TABLE 1: Summaries for All Dialysis Patients Treated as of December 31st of Each Year *1 , 2012-2015
Measure Name
2012
2013
2014
2015
- State *2 Network *2
U.S. *2
2015
1a Patients treated on 12/31 (n)
162
151
148
157
97.4
108
66.9
1b Average age (years)
48.3
48.1
50.4
48.2
62.1
61.8
61.7
< 18
4.9
2.0
1.4
7.0
0.3
0.3
0.3
18-64
70.4
74.2
72.3
70.1
53.7
54.5
54.6
65+
24.7
23.8
26.4
22.9
46.0
45.2
45.2
51.9
47.0
49.3
48.4
42.5
41.9
43.5
8.6
9.3
10.1
10.8
14.7
13.8
35.5
13.6
11.3
11.5
12.1
16.9
13.7
5.7
1c Age (% of 1a; sums to 100%)
1d Female (% of 1a)
Asian/Pacific Islander
Native American
White
Other/Unknown/Missing
1f Ethnicity (% of 1a; sums to 100%)
Hispanic
Non-Hispanic
Unknown
1g Primary Cause of ESRD (% of 1a; sums to 100%)
2.0
2.0
1.9
0.4
0.3
1.2
75.5
73.6
72.6
67.4
71.6
57.3
1.9
2.0
2.7
2.5
0.5
0.6
0.3
56.2
58.9
56.1
52.9
42.7
49.7
18.4
43.8
41.1
43.9
47.1
56.9
49.9
81.2
0.0
0.0
0.0
0.0
0.5
0.5
0.4
33.3
31.8
32.4
34.4
50.5
50.9
45.0
Hypertension
15.4
17.2
16.9
15.9
26.5
27.6
29.4
Glomerulonephritis
24.1
25.8
27.0
24.2
10.5
9.8
11.1
Other/Unknown
26.5
24.5
23.0
24.8
11.4
10.8
13.5
0.6
0.7
0.7
0.6
1.1
0.9
1.1
7.3
7.6
7.6
7.3
5.1
5.1
4.9
Sa
m
Diabetes
1.9
74.1
pl
African American
e
1e Race (% of 1a; sums to 100%) *3
Missing
1h Average duration of ESRD (years)
1i Years since start of ESRD (% of 1a; sums to 100%)
<1
18.5
9.3
10.1
12.7
14.4
14.1
16.1
1-2
13.0
16.6
12.2
13.4
16.1
15.9
17.0
2-3
9.3
11.3
14.2
8.9
13.5
13.4
13.6
3-6
16.7
20.5
21.6
24.2
27.3
27.5
26.2
6+
42.6
42.4
41.9
40.8
28.8
29.1
27.1
0.6
2.6
2.7
7.0
12.0
11.9
14.8
73.5
73.5
71.6
72.0
87.0
88.0
87.6
Home hemodialysis
0.0
0.0
0.0
0.0
1.1
1.0
1.8
Continuous ambulatory peritoneal dialysis
1.9
1.3
2.0
0.6
2.1
2.0
1.8
24.1
25.2
26.4
27.4
9.3
8.6
8.3
0.6
0.0
0.0
0.0
0.5
0.4
0.5
1j Nursing home patients (% of 1a) *4
1k Modality (% of 1a; sums to 100%)
In-center hemodialysis
Continuous cycling peritoneal dialysis
Other modality
*5
n/a = not applicable
[*1] See Guide, Section IV.
[*2] Values are shown for the average facility.
[*3] 'Asian' includes Indian sub-continent. 'Native American' includes Alaskan Native. 'White' includes Middle Eastern and Arabian.
[*4] Includes patients who were also treated by a nursing facility at any time during the year. The source of nursing facility history of patients is the Nursing Home Minimum Dataset.
[*5] Other modality includes other dialysis, uncertain modality, and patients not on dialysis but still temporarily assigned to the facility (discontinued dialysis, recovered renal function, and lost to follow up).
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
---
Produced by The University of Michigan Kidney Epidemiology and Cost Center (July 2016)
4/22
Dialysis Facility Report for FY (FY) 2017
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE
TABLE 2: Characteristics of New Dialysis Patients *1 , 2012-2015 (Form CMS-2728)
Measure Name
2012
2013
2014
- State *2 Network *2
2015
Patient Characteristics *3
U.S. *2
2015
2a Total number of patients with forms (n)
35
30
28
34
22.2
24.3
17.7
47.8
51.7
51.9
40.4
63.8
64.0
63.4
48.6
36.7
46.4
52.9
41.3
41.4
42.4
8.6
10.0
25.0
5.9
12.1
11.3
26.5
17.1
6.7
10.7
8.8
16.4
14.0
5.2
2.9
0.0
0.0
0.0
0.3
0.3
0.9
65.7
83.3
60.7
82.4
70.6
74.1
67.1
5.7
0.0
3.6
2.9
0.5
0.4
0.3
51.4
43.3
28.6
61.8
34.7
40.4
15.0
31.4
46.7
50.0
35.3
53.7
53.8
48.0
17.1
16.7
17.9
11.8
27.1
28.6
29.6
22.9
16.7
3.6
11.8
6.8
6.4
7.5
28.6
20.0
28.6
41.2
12.3
11.1
14.9
22.9
10.0
28.6
20.6
11.1
10.6
12.6
8.6
6.7
3.6
0.0
22.3
22.3
31.4
8.6
26.7
7.1
17.6
19.6
20.8
12.1
22.9
16.7
21.4
32.4
19.6
20.0
13.2
5.7
20.0
21.4
0.0
15.7
14.6
19.0
Other/Unknown
14.3
10.0
17.9
29.4
10.7
10.6
7.5
None
17.1
10.0
0.0
0.0
1.0
1.2
4.2
Male
25.5
24.1
26.3
31.1
26.9
26.8
27.8
Female
26.2
27.5
30.6
26.7
27.5
27.5
29.1
Six months prior to ESRD treatment
57.1
28.6
36.4
53.3
32.4
31.6
31.7
At first ESRD treatment
14.3
21.4
36.4
46.7
23.3
22.4
22.6
Hemodialysis
74.3
70.0
57.1
55.9
87.9
89.8
89.9
CAPD/CCPD
25.7
30.0
42.9
44.1
12.1
10.2
10.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
26
21
16
19
19.5
21.8
15.9
0.0
23.8
6.3
5.3
17.3
15.2
16.9
2b Average age (years [0-95]) *3
2c Female (% of 2a)
2d Race (% of 2a; sums to 100%)
*4
African-American
Asian/Pacific Islander
Native American
White
Other/Unknown
e
2e Hispanic (% of 2a)
2f Primary cause of ESRD (% of 2a; sums to 100%)
Diabetes
Primary glomerulonephritis
Other/Unknown
2g Medical coverage (% of 2a; sums to 100%)
Employer group only
Medicare only
Sa
m
Medicaid only
pl
Hypertension
Medicare and Medicaid only
Medicare and other
*5
2h Body Mass Index (Median; Weight/Height^2)
2i Employment *6
2j Primary modality (% of 2a; sums to 100%)
Other/Unknown/Missing
2k Number of incident hemodialysis patients (n)
2l Access used at first outpatient dialysis (% of 2k; sums to 100%)
Arteriovenous fistula
Arteriovenous graft
Catheter
Other/Unknown/Missing
2m Arteriovenous fistula placed (% of 2k)
3.8
0.0
0.0
0.0
3.2
2.6
3.0
96.2
76.2
93.8
94.7
79.2
82.0
80.0
0.0
0.0
0.0
0.0
0.2
0.2
0.2
7.7
28.6
6.3
10.5
30.4
27.1
33.6
(continued)
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
---
Produced by The University of Michigan Kidney Epidemiology and Cost Center (July 2016)
5/22
Dialysis Facility Report for FY (FY) 2017
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE
TABLE 2 (cont.): Characteristics of New Dialysis Patients *1 , 2012-2015 (Form CMS-2728)
Measure Name
2012
2013
2014
- State *2 Network *2
2015
Average Lab Values Prior to Dialysis *3
U.S. *2
2015
2n Hemoglobin (g/dL [3-18])
9.2
9.2
9.6
8.9
9.5
9.5
9.4
2o Serum albumin (g/dL [0.8-6.0])
3.5
3.3
3.5
3.2
3.2
3.2
3.2
2p Serum creatinine (mg/dL [2-33])
8.0
7.2
6.6
6.8
6.3
6.3
6.5
2q GFR (mL/min [0-60])
8.1
9.2
9.6
8.1
10.7
10.7
10.7
37.1
23.3
46.4
58.8
15.5
12.7
13.4
No
31.4
36.7
21.4
44.1
21.4
22.9
22.9
Yes, < 6 months
25.7
13.3
32.1
14.7
16.6
17.3
13.5
Yes, 6-12 months
8.6
16.7
3.6
11.8
19.5
17.3
19.5
34.3
33.3
42.9
29.4
23.4
20.2
29.9
Care Prior to ESRD Therapy
2r Received ESA prior to ESRD (% of 2a)
Unknown/Missing
2t Informed of transplant options (% of 2a)
2u Patients not informed of transplant options (n)
2v Reason not informed (% of 2u; may not sum to 100%)
Medically unfit
Unsuitable due to age
Psychologically unfit
0.0
0.0
0.0
0.0
19.1
22.2
14.2
65.7
60.0
89.3
100
87.8
87.6
86.8
12
12
3
0
2.7
3.0
2.3
8.3
0.0
0.0
.
30.0
26.2
36.0
0.0
0.0
33.3
.
27.3
30.7
25.8
0.0
0.0
0.0
.
2.6
2.4
3.4
0.0
0.0
.
2.4
3.0
1.9
91.7
0.0
100
66.7
.
43.0
48.3
37.1
20.0
23.3
17.9
14.7
24.1
23.4
28.8
11.4
20.0
17.9
8.8
9.6
8.8
14.0
2.9
10.0
25.0
29.4
14.9
15.8
20.0
CVD, CVA, TIA
2.9
3.3
0.0
2.9
5.8
5.8
8.4
Peripheral vascular disease
0.0
0.0
0.0
2.9
6.6
6.2
10.4
Sa
m
Patient declined information
e
Yes, > 12 months
pl
2s Pre-ESRD nephrologist care (% of 2a; sums to 100%)
*7
Patient has not been assessed
Comorbid Conditions
2w Pre-existing comorbidity (% yes of 2a) *7
Congestive heart failure
Atherosclerotic heart disease
Other cardiac disorder
*8
*7
History of hypertension
82.9
90.0
89.3
94.1
85.9
86.6
87.6
*7
37.1
60.0
57.1
38.2
64.8
65.2
62.6
Diabetes on insulin
Diabetes
25.7
36.7
46.4
32.4
38.1
38.0
41.6
COPD
0.0
3.3
0.0
5.9
4.9
4.8
9.3
Current smoker
2.9
3.3
0.0
0.0
2.6
2.2
6.1
Cancer
0.0
3.3
7.1
20.6
4.6
4.5
7.0
Alcohol dependence
0.0
0.0
3.6
0.0
1.5
1.5
1.5
Drug dependence
0.0
0.0
0.0
0.0
1.1
0.8
1.2
Inability to ambulate
0.0
3.3
0.0
0.0
7.0
8.1
7.1
Inability to transfer
0.0
0.0
0.0
0.0
4.3
5.2
3.9
1.9
2.6
2.6
2.5
2.8
2.8
3.1
2x Average number of comorbid conditions
n/a= not applicable
[*1] See Guide, Section V.
[*2] Values are shown for the average facility.
[*3] For continuous variables, summaries include only responses in range indicated in brackets.
[*4] 'Asian' includes Indian sub-continent. 'Native American' includes Alaskan Native. 'White' includes Middle Eastern and Arabian.
[*5] The median BMI is computed for adult patients at least 20 years old with height, weight, and BMI values in acceptable ranges. Acceptable range for height, weight, and BMI are 122-208cm, 32-318 kg, and 10-55 respectively.
[*6] Full-time, part-time, or student (% of 18-60 year olds).
[*7] Values may not sum to exactly 100% because of patients that received nephrology care but duration unknown (0.01% in US in 2015).
[*8] 'Atherosclerotic heart disease' includes ischemic heart disease (coronary artery disease) and myocardial infarction. 'Other cardiac disorder' includes cardiac arrest, cardiac dysrhythmia, and pericarditis. 'Diabetes' includes
patients with diabetes as the primary cause of ESRD.
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
---
Produced by The University of Michigan Kidney Epidemiology and Cost Center (July 2016)
6/22
Dialysis Facility Report for FY (FY) 2017
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE
TABLE 3: Mortality Summary for All Dialysis Patients (2012-15) & New Dialysis Patients (2012-14) *1
Measure Name
2012
2013
2014
2015
2012-2015
State *2 Network *2
All Patients: Death Rates
U.S. *2
2012-2015
209
199
190
193
791 *8
121.4
132.6
95.5
159.2
156.4
153.4
154.5
623.4 *8
90.0
98.9
64.2
8
12
15
18
53 *8
13.2
14.3
11.2
16.2
15.7
14.6
16.1
62.7 *8
13.6
14.7
11.2
3e Withdrawal from dialysis prior to death (% of 3c)
37.5
41.7
33.3
16.7
30.2
20.8
17.7
24.9
3f Death due to Infections (% of 3c)
37.5
50.0
33.3
11.1
30.2
11.7
11.8
11.7
75.0
66.7
20.0
77.8
58.5
48.0
52.8
43.5
0
*8
0.1
0.1
0.1
3a Patients (n=number)
3b Patient-years (PY) at risk (n)
3c Deaths (n)
3d Expected deaths (n)
All Patients: Categories of Death
Death due to Cardiac causes (% of 3c)
*3
1
All Patients: Standardized Mortality Ratio (SMR)
0.76
1.03
1.12
0.85
0.97
0.97
1.00
0.038
0.423
0.988
0.695
0.243
n/a
n/a
n/a
*6
High (97.5% limit)
Low (2.5% limit)
3k SMR percentiles for this facility *7
In this State
In this Network
0.97
1.33
1.69
1.77
1.11
n/a
n/a
n/a
0.21
0.39
0.57
0.66
0.63
n/a
n/a
n/a
8
31
59
69
29
n/a
n/a
n/a
7
30
57
67
28
n/a
n/a
n/a
65
28
n/a
n/a
n/a
10
28
58
2012
2013
2014
2012-2014
35
30
28
93 *8
22.1
24.3
17.0
25.6
85.7
*8
19.7
21.6
14.9
10
*8
3.9
4.4
3.4
11.1
*8
3.9
4.3
3.4
Sa
m
In the U.S.
1
0.49
*5
3j Confidence interval for SMR
0
pl
3h SMR *4
3i P-value
0
e
3g Dialysis unrelated deaths (n; excluded from SMR)
New Patients: First Year Death Rates
3l New patients (n=number)
3m Patient-years (PY) at risk (n)
3n Deaths (n)
32.8
3
3o Expected deaths (n)
3.2
27.3
5
2
4.0
3.9
2012-2014
New Patients: Categories of Deaths
3p Withdrawal from dialysis prior to death (% of 3n)
33.3
0.0
50.0
20.0
21.5
18.6
26.6
3q Death due to Infections (% of 3n)
33.3
20.0
0.0
20.0
10.8
11.0
10.8
33.3
40.0
100
50.0
42.1
45.8
38.9
0.93
1.25
0.52
0.90
1.00
1.02
1.00
0.999
0.748
0.511
0.891
n/a
n/a
n/a
High (97.5% limit)
2.72
2.91
1.86
1.65
n/a
n/a
n/a
Low (2.5% limit)
0.19
0.40
0.06
0.43
n/a
n/a
n/a
In this State
50
68
28
46
n/a
n/a
n/a
In this Network
50
66
26
43
n/a
n/a
n/a
In the U.S.
50
67
26
46
n/a
n/a
n/a
Death due to Cardiac causes (% of 3n)
New Patients: First Year Standardized Mortality Ratio (SMR)
3r SMR *4
3s P-value *5
3t Confidence interval for SMR
*6
3u First Year SMR percentiles for this facility *7
n/a = not applicable
[*1] See Guide, Section VI.
[*2] Values are shown for the average facility, annualized.
[*3] Defined as deaths due to street drugs and accidents unrelated to treatment.
[*4] Calculated as a ratio of deaths to expected deaths (3c to 3d for all patients, 3n to 3o for new patients);not shown if there are fewer than 3 expected deaths.
[*5] A p-value less than 0.05 indicates that the difference between the actual and expected mortality is probably real and is not due to random chance alone, while a p-value greater than or equal to 0.05 indicates that the difference
could plausibly be due to random chance.
[*6] The confidence interval range represents uncertainty in the value of the SMR due to random variation.
[*7] All facilities are included in ranking, regardless of the number of expected deaths.
[*8] Sum of 4 years (all patients) or 3 years (new patients) used for calculations; should not be compared to regional averages.
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
---
Produced by The University of Michigan Kidney Epidemiology and Cost Center (July 2016)
7/22
Dialysis Facility Report for FY (FY) 2017
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE
TABLE 4: Hospitalization Summary for Medicare Dialysis Patients *1 , 2012-2015
Measure Name
2012
2013
2014
2015
2012-2015
State *2 Network *2
Medicare Dialysis Patients
U.S. *2
2012-2015
4a Medicare dialysis patients (n)
151
154
147
136
588 *3
82.4
89.3
74.1
4b Patient-years (PY) at risk (n)
117.8
118.5
114.5
107.9
458.6 *3
53.4
57.7
45.4
859
1167
1109
931
4066 *3
605.1
697.3
599.8
*3
691.6
748.8
601.9
Days Hospitalized Statistics
4c Total days hospitalized (n)
4d Expected total days hospitalized (n)
1460.8
1416.9
1311.4
1225.7
0.59
0.82
0.85
0.76
0.75
0.88
0.93
1.00
0.149
0.572
0.624
0.464
0.322
n/a
n/a
n/a
High (97.5% limit)
1.19
1.47
1.52
1.48
1.29
n/a
n/a
n/a
Low (2.5% limit)
0.31
0.50
0.50
0.42
0.46
n/a
n/a
n/a
In this State
17
48
51
37
32
n/a
n/a
n/a
In this Network
11
39
43
31
23
n/a
n/a
n/a
4e Standardized Hospitalization Ratio (Days)
*5
4g Confidence interval for SHR (Days)
*6
pl
4h Percentiles for this facility (Days) *7
In the U.S.
Admission Statistics
4i Total admissions (n)
4j Expected total admissions (n)
*4
15
38
41
30
25
n/a
n/a
n/a
147
151
164
155
617 *3
91.2
101.3
82.7
*3
95.2
102.8
82.8
215.6
207.4
190.5
179.7
0.68
0.73
0.86
0.86
0.78
0.96
0.99
1.00
Sa
m
4k Standardized Hospitalization Ratio (Admissions)
4l P-value
5414.8
e
4f P-value
*4
*5
793.2
0.156
0.222
0.581
0.607
0.270
n/a
n/a
n/a
High (97.5% limit)
1.15
1.19
1.37
1.39
1.19
n/a
n/a
n/a
Low (2.5% limit)
0.43
0.47
0.57
0.57
0.53
n/a
n/a
n/a
In this State
14
19
40
40
22
n/a
n/a
n/a
In this Network
10
16
38
37
18
n/a
n/a
n/a
14
18
36
35
20
n/a
n/a
n/a
13.2
13.6
17.0
11.8
13.9
11.7
11.9
10.9
2.0
4.5
3.4
5.1
3.7
4.2
4.2
4.1
19.9
16.9
23.1
22.1
20.4
21.4
21.5
23.4
Cardiac dysrhythmia
9.3
5.8
10.9
11.0
9.2
14.5
14.1
15.9
Cardiac arrest
2.0
1.3
2.7
1.5
1.9
2.0
2.0
2.1
17.7
10.6
9.8
12.3
12.5
13.3
12.9
11.5
5.8
7.7
6.8
6.0
6.6
6.6
6.9
7.3
4m Confidence interval for SHR (Admissions)
*6
4n Percentiles for this facility (admissions) *7
In the U.S.
4o Diagnoses associated with hospitalization (% of 4a)
Septicemia
Acute myocardial infarction
Congestive heart failure
4p One day admissions (% of 4i)
4q Average length of stay (days per admission; 4c/4i)
*8
(continued)
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
---
Produced by The University of Michigan Kidney Epidemiology and Cost Center (July 2016)
8/22
Dialysis Facility Report for FY (FY) 2017
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE
TABLE 4 (cont.): Hospitalization Summary for Medicare Dialysis Patients *1 , 2012-2015
Measure Name
2012
2013
2014
2015
2012-2015
State *2 Network *2
2012-2015
4r Total ED visits (n)
262
283
270
251
1066 *3
137.8
148.0
138.7
4s Expected total ED visits (n)
392
386
365
342
1484 *3
159.8
172.7
139.2
4t Standardized Hospitalization Ratio (ED) *4
0.67
0.73
0.74
0.73
0.72
0.86
0.86
1.00
0.109
0.165
0.195
0.206
0.105
n/a
n/a
n/a
1.09
1.12
1.15
1.16
1.07
n/a
n/a
n/a
0.44
0.52
0.52
0.50
0.51
n/a
n/a
n/a
In this State
22
30
32
32
25
n/a
n/a
n/a
In this Network
21
29
31
31
23
n/a
n/a
n/a
In the U.S.
11
17
17
16
11
n/a
n/a
n/a
4x Patients with ED visit (% of 4a)
58.3
59.7
56.5
62.5
59.2
57.5
58.3
60.8
4y ED visits that result in hospitalization (% of 4t)
44.7
44.2
48.5
51.4
47.1
50.8
53.6
47.8
pl
Emergency Department (ED) Statistics
U.S. *2
78.3
80.2
4u P-value
*5
4v Confidence interval for SHR (ED) *6
High (97.5% limit)
Low (2.5% limit)
4z Admissions that originate in the ED (% of 4i)
Readmission Statistics
4aa Index discharges (n)
4ab Total readmissions (n)
4ac Expected total readmissions (n)
79.6
82.8
4ae P-value
*5
4af Confidence interval for SRR
79.9
83.2
81.4
76.8
2015
140
130
138
127
n/a
86.9
96.7
77.2
30
41
33
39
n/a
21.9
24.4
20.3
38
39
37
34
n/a
21.8
23.9
20.7
0.79
1.06
0.88
1.15
n/a
1.0
1.0
1.0
0.460
0.713
n/a
n/a
n/a
n/a
Sa
m
4ad Standardized Readmission Ratio (SRR)
e
4w Percentiles for this facility (ED)
*7
0.197
0.875
*6
n/a
High (97.5% limit)
1.16
1.35
1.19
1.58
n/a
n/a
n/a
n/a
Low (2.5% limit)
0.49
0.80
0.62
0.77
n/a
n/a
n/a
n/a
n/a = not applicable.
[*1] Based on patients with Medicare as primary insurer; see Guide, Section VII.
[*2] Values are shown for the average facility, annualized.
[*3] Sum of 4 years used for calculations; should not be compared to regional averages.
[*4] Standardized Ratios are calculated as ratio of actual to expected events (4c/4d for days, 4i/4j for admissions, 4r/4s for ED visits, and 4ab/4ac for readmissions). SHRs are not shown if there are less than 5 patient years at risk.
SRR is not shown if fewer than 11 index discharges in the year.
[*5] A p-value less than 0.05 indicates that the difference between the actual and expected event is probably real and is not due to random chance alone, while a p-value greater than or equal to 0.05 indicates that the difference could
plausibly be due to random chance.
[*6] The confidence interval range represents uncertainty in the value of the standardized hospitalization and readmission ratios (SHRs and SRR) due to random variation.
[*7] All facilities are included in ranking, regardless of the number of patient years at risk.
[*8] Includes diagnoses present at admission and diagnoses added during the hospital stay.
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
---
Produced by The University of Michigan Kidney Epidemiology and Cost Center (July 2016)
9/22
Dialysis Facility Report for FY (FY) 2017
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE
TABLE 5: Transplantation Summary for Dialysis Patients under Age 70 *1 , 2012-2015
Measure Name
2012
2013
2014
2015
2012-2015
State *2 Network *2
All patients
U.S. *2
2012-2015
5a Eligible patients (n)
5b Transplants (n)
177
169
156
158
660 *10
82.6
90.8
65.4
16
15
12
9
52 *10
2.7
2.6
1.9
6
4
2
3
15 *10
0.7
0.7
0.5
10
11
10
6
37 *10
2.0
1.9
1.5
131
127
115
122
495 *10
76.3
84.2
59.7
96.4
385.2
*10
57.0
63.5
40.7
35
*10
2.3
2.2
1.7
5c Donor type (sums to 5b) *3
Living donor (n)
Deceased donor (n)
Patients who have not Previously Received a Transplant
5d Eligible patients (n)
5e Patient years (PY) at risk (n)
94.6
9
5g Expected first transplants (n)
Standardized 1st Transplantation Ratio (STR)
5h STR *6
5i P-value
*7
5j Confidence interval for STR
*8
High (97.5% limit)
6.9
*5
12
96.6
6
8
e
(n)
97.7
6.4
6.0
7.9
*10
2.4
2.7
1.7
1.29
0.97
0.82
1.00
0.164
n/a
n/a
n/a
27.1
pl
5f First transplants
*4
1.79
n/a
n/a
n/a
0.90
n/a
n/a
n/a
73
n/a
n/a
n/a
In this Network
85
n/a
n/a
n/a
In the U.S.
68
n/a
n/a
n/a
Low (2.5% limit)
5k STR percentiles for this facility *9
Sa
m
In this State
n/a = not applicable.
[*1] See Guide, Section VIII.
[*2] Values are shown for the average facility, annualized.
[*3] Values may not sum to 5b due to unknown donor type.
[*4] Among first transplants that occurred after the start of dialysis from 2012-2015, 3.8% of transplants in the U.S. were not included because the transplant occurred fewer than 90 days after the start of ESRD and 1.1% were not
included because the patient was not assigned to a facility at time of transplant.
[*5] This section is calculated for the 4-year period only and not reported if there are fewer than 3 expected transplants.
[*6] Standardized 1st Transplantation Ratio calculated as ratio of actual (5f) to expected (5g) transplants.
[*7] A p-value less than 0.05 indicates that the difference between the actual and expected transplants is probably real and is not due to random chance, while a p-value greater than or equal to 0.05 indicates that the difference is
plausibly due to random chance.
[*8] The confidence interval range represents uncertainty in the value of the STR due to random variation.
[*9] All facilities are included in ranking, regardless of the number of expected transplants.
[*10] Sum of 4 years used for calculations; should not be compared to regional averages.
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
---
Produced by The University of Michigan Kidney Epidemiology and Cost Center (July 2016)
10/22
Dialysis Facility Report for FY (FY) 2017
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE
TABLE 6: Waitlist Summary for Dialysis Patients under Age 70 Treated on December 31st of Each Year *1 , 2012-2015
Measure Name
2012
2013
2014
2015
- State *2 Network *2
U.S. *2
2015
6a Eligible patients on 12/31 (n)
136
142
127
143
69.0
76.8
48.2
6b Patients on the waitlist (% of 6a)
45.6
41.5
44.1
42.7
31.2
26.0
22.6
<0.01
<0.01
<0.01
<0.01
n/a
n/a
n/a
Age < 40
58.6
51.7
52.8
40.7
43.6
38.6
33.1
Age 40-69
35.9
34.1
37.8
44.0
29.5
24.2
21.2
Male
44.8
37.3
38.7
35.2
32.2
26.9
23.7
Female
46.4
46.3
49.2
50.0
29.8
24.4
21.0
African American
50.0
50.0
58.3
46.7
27.2
22.7
21.0
Asian/Pacific Islander
50.0
54.5
50.0
60.0
41.2
31.9
33.2
Native American
33.3
33.3
33.3
33.3
22.0
16.3
15.5
White, Hispanic
40.7
39.8
41.4
35.9
30.5
26.0
25.4
White, non-Hispanic
55.6
37.9
42.3
50.0
29.1
24.4
21.6
(compared to U.S. value)
Other/unknown race
Diabetes
Non-diabetes
Previous kidney transplant
66.7
50.0
50.0
50.0
36.5
34.6
24.9
28.9
31.6
37.5
37.5
26.7
21.4
18.4
52.0
45.2
46.3
44.7
35.8
30.6
26.0
55.9
57.1
45.5
45.5
44.8
39.4
40.1
42.2
36.4
43.6
41.8
30.1
24.9
21.1
Sa
m
No previous kidney transplant
e
6d Patients on the waitlist by subgroup (%)
*4
pl
6c P-value
*3
< 2 years since start of ESRD
38.1
35.6
41.9
35.9
19.1
13.9
15.3
2-4 years since start of ESRD
48.1
29.0
54.5
52.6
37.2
31.7
28.1
5+ years since start of ESRD
49.3
51.5
39.7
40.9
37.2
31.6
25.3
n/a = not applicable.
[*1] See Guide, Section IX.
[*2] Values are shown for the average facility.
[*3] Facility waitlist percentage is compared to the U.S. waitlist percentage for that year: 24.3% (2012), 24.4% (2013), 24.0% (2014), 22.6% (2015). A p-value greater than 0.05 indicates that the difference between percent of
patients wailisted at the facility and national percentage is plausibly due to random chance.
[*4] A missing value indicates that there were no eligible patients in the subgroup.
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
---
Produced by The University of Michigan Kidney Epidemiology and Cost Center (July 2016)
11/22
Dialysis Facility Report for FY (FY) 2017
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE
TABLE 7: Influenza Vaccination Summary for Medicare Dialysis Patients Treated on December 31st of Each Year *1 , Flu
Seasons August 2012-December 2015
Measure Name
2012
2013
2014
2015
- State *2 Network *2
U.S. *2
2015
7a Eligible patients on 12/31 (n)
118
7b Patients vaccinated between Aug. 1 and Dec. 31 (% of 7a)
7c P-value *3 (for 7b compared to U.S. value *4)
123
110
106
56.7
61.0
46.9
69.5
64.2
81.8
75.5
73.2
71.6
73.3
0.436
0.050
0.031
0.353
n/a
n/a
n/a
2014
7d Patients vaccinated between Aug 1 and Mar 31 of following year (% of 7a)
*3
*5
7e P-value (for 7d compared to U.S. value )
69.5
65.9
81.8
73.3
71.4
74.2
0.343
0.074
0.038
n/a
n/a
n/a
2015
7f Patients vaccinated between Aug 1 and Dec 31 by subgroup (%)
*6
100
50.0
100
0.0
61.4
62.2
57.5
Age 18-39
69.7
60.5
76.7
78.6
69.0
67.0
69.9
Age 40-64
62.2
61.4
79.1
70.5
74.0
72.8
73.8
Age 65-74
78.6
71.4
92.3
87.0
71.8
69.9
72.8
Age 75+
70.0
72.7
80.0
70.0
74.2
72.4
74.1
72.2
65.6
84.5
74.1
73.4
72.2
73.5
67.2
62.9
78.8
76.9
72.8
70.7
73.1
66.7
66.7
66.7
66.7
65.5
62.9
71.0
88.2
61.5
75.0
54.5
78.2
76.7
76.7
66.7
66.7
100
100
75.3
74.2
80.0
66.7
66.0
85.4
79.7
73.5
72.2
74.4
Other/unknown race
50.0
25.0
50.0
50.0
71.9
71.6
68.5
Hispanic
69.1
67.1
81.0
75.9
76.3
74.8
75.0
< 1 year since start of ESRD
66.7
42.9
100
60.0
58.6
56.2
59.7
1-2 years since start of ESRD
69.2
72.2
86.7
73.9
73.3
71.7
72.4
3+ years since start of ESRD
70.1
64.4
77.1
76.9
76.5
75.0
77.2
Female
African American
Asian/Pacific Islander
Native American
Sa
m
White
pl
Male
e
Age < 18
n/a = not applicable
[*1] Based on patients with Medicare as primary insurer; see Guide, Section X.
[*2] Values are shown for the average facility.
[*3] A p-value greater than or equal to 0.05 indicates that the difference between percent of patients vaccinated at the facility and national percentage is plausibly due to random chance.
[*4] Compared to the U.S. value for that year and time period (8/1-12/31): 70.5% (2012), 71.4% (2013), 73.8% (2014), 73.3% (2015).
[*5] Compared to the U.S. value for that year and time period (8/1-3/31): 71.5% (2012), 72.2% (2013), 74.2% (2014).
[*6] A missing value indicates that there were no eligible patients in the subgroup.
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
---
Produced by The University of Michigan Kidney Epidemiology and Cost Center (July 2016)
12/22
Dialysis Facility Report for FY (FY) 2017
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE
TABLE 8: Anemia Management *1 , 2012-2015
Measure Name
2012
2013
2014
- State *2 Network *2
2015
Hemoglobin and ESA-CROWNWeb
U.S. *2
2015
8a Eligible patients (n) *3
176
183
185
176
122.4
134.5
86.4
8b Eligible patient-months (n) *4
1184
1784
1765
1733
1113.8
1228.0
760.2
8c Average hemoglobin *5 (g/dL) (average of 8b)
11.2
10.8
10.7
10.6
10.8
10.8
10.8
<10 g/dL
11.7
24.0
26.1
25.7
18.5
18.8
20.5
10-<11 g/dL
26.9
29.7
30.7
34.2
34.1
34.4
33.1
11-12 g/dL
37.1
25.3
23.4
24.1
28.6
28.4
28.3
>12 g/dL
18.8
15.6
13.7
9.8
10.9
10.9
12.2
5.6
5.4
6.1
6.2
7.9
7.4
5.9
79.4
77.0
73.5
74.6
66.0
69.5
67.6
8f Adult Medicare patients (n)
132
131
129
117
75.8
82.1
60.3
8g Patient years (PY) at risk (n)
93
101
97
89
45.8
49.3
36.6
8d Hemoglobin categories (% of 8b; sums to 100%)
Missing/Out of range
e
8e ESA prescribed (% of 8b)
8h Total transfusions (n)
8i Expected total transfusions (n)
8j Standardized Transfusion Ratio
*6
Upper Confidence Limit (97.5%)
Lower Confidence Limit (2.5%)
50
29
30
14.9
18.0
14.1
40.9
36.4
31.2
17.8
19.2
14.4
0.78
1.22
0.80
0.96
0.84
0.94
1.00
1.54
2.06
1.56
1.85
n/a
n/a
n/a
0.44
0.78
0.44
0.55
n/a
n/a
n/a
0.536
0.336
0.563
0.990
n/a
n/a
n/a
Sa
m
8k P-value *7
31
39.6
pl
Standardized Transfusion Ratio (STrR)
Hemoglobin-Medicare Claims *8
8l Eligible hemodialysis (HD) patients (n) *8
95
96
86
87
48.3
51.5
36.3
5.3
12.5
16.3
12.6
12.1
13.3
16.5
10-<11 g/dL
30.5
59.4
59.3
57.5
67.2
68.3
65.1
11-12 g/dL
62.1
28.1
24.4
28.7
20.4
18.2
18.1
> 12 g/dL
2.1
0.0
0.0
1.1
0.3
0.2
0.3
23
18
21
18
4.3
4.5
3.3
8m Hemoglobin categories among HD pts (% of 8l; sums to 100%)
< 10 g/dL
8n Eligible peritoneal dialysis (PD) patients (n) *8
8o Hemoglobin categories among PD pts (% of 8n; sums to 100%)
< 10 g/dL
8.7
16.7
28.6
27.8
23.0
22.9
26.4
10-<11 g/dL
73.9
66.7
52.4
66.7
57.6
57.2
57.2
11-12 g/dL
17.4
16.7
19.0
0.0
18.3
18.4
15.7
> 12 g/dL
0.0
0.0
0.0
5.6
1.1
1.5
0.6
n/a = not applicable
[*1] See Guide, Section XI.
[*2] Values are shown for the average facility.
[*3] Includes those who switch between HD and PD during the month and patients for whom modality is unknown.
[*4] Patients may be counted up to 12 times per year.
[*5] Based on in-range values; see Guide for range values.
[*6] Calculated as a ratio of observed transfusions to expected transfusions (8h to 8i); not shown if there are fewer that 10 patient-years at risk for transfusions.
[*7] A p-value less than 0.05 indicates that the difference between the actual and expected transfusion is probably real and is not due to random chance alone, while a p-value greater than or equal to 0.05 indicates that the difference
could plausibly be due to random chance.
[*8] Among ESA-treated dialysis patient with ESRD for 90+ days and 4 or more claims at this facility.
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
---
Produced by The University of Michigan Kidney Epidemiology and Cost Center (July 2016)
13/22
Dialysis Facility Report for FY (FY) 2017
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE
TABLE 9: Dialysis Adequacy *1 , May 2012-2015
Measure Name
2012
2013
2014
- State *2 Network *2
2015
Hemodialysis Adequacy
U.S. *2
2015
9a Eligible HD patients (n)
137
139
134
133
112.0
124.5
79.2
922
1348
1291
1288
1015.5
1131.7
694.1
0.3
0.5
0.7
1.0
1.0
0.9
100
99.9
99.9
99.8
30.0
35.0
29.1
7.5
7.8
8.1
8.1
8.8
8.8
8.1
<=13 (ml/kg/hr)
80.0
79.4
77.7
80.7
44.2
45.6
55.6
>13 (ml/kg/hr)
10.6
12.5
13.7
11.2
9.0
9.2
7.9
9.3
8.2
8.6
8.1
46.8
45.2
36.5
112
121
119
114
104.1
114.3
74.9
709
1118
1086
1091
914.1
1006.3
643.5
1.6
1.7
1.7
1.8
1.6
1.6
1.6
9b Eligible HD patient-months (n)
*3
9c Average normalized protein catabolic rate (nPCR)
*4
(average of 9b)
9d nPCR Missing/Out of range (% of 9b)
9e Ultrafiltration Rate: Average
*4
(ml/kg/hr) (average of 9b)
9f Ultrafiltration Rate categories (% of 9b; sums to 100%)
Missing/Out of range
9h Eligible HD Kt/V patient-months (n)
9i Average Kt/V
*4
e
9g Eligible HD Kt/V patients (n)
*5
*3 *5
(average of 9h)
pl
9j Kt/V categories (% of 9h; sums to 100%)
<1.2
1.2-<1.8
>=1.8
Missing/Out of range
Peritoneal Dialysis Adequacy
*6
4.6
2.5
0.9
3.4
3.4
3.2
65.6
65.1
59.8
61.6
68.3
68.2
68.1
29.3
30.1
37.3
36.0
23.4
23.8
24.9
0.0
0.3
0.5
1.5
5.0
4.6
3.8
40
46
53
48
31.2
29.4
20.3
Sa
m
9k Eligible PD patients (n)
5.1
9l Eligible PD patient-months (n)
*3
261
432
470
435
266.3
252.7
161.7
2.1
2.0
2.1
2.2
2.3
2.3
2.3
7.7
6.7
10.6
6.7
7.1
7.9
7.6
1.7-<2.5
56.0
56.7
49.8
52.0
58.2
56.7
59.8
>=2.5
14.3
8.1
11.7
16.6
23.2
22.9
24.4
Missing/Out of range
22.0
28.5
27.9
24.8
11.5
12.5
8.2
0.9
1.0
0.9
1.0
0.8
0.8
0.8
50.6
29.2
73.0
76.6
83.8
82.7
80.5
119
126
112
104
74.3
80.9
65.2
1092
1098
1026
1031
561.4
609.1
471.5
9m Average weekly Kt/V (average of 9l)
9n Weekly Kt/V categories (% of 9l; sums to 100%)
<1.7
9o Average normalized protein catabolic rate (nPCR) *4 (average of 9l)
9p nPCR Missing/Out of range (% of 9l)
Adult Kt/V--Medicare Claims
*7
9q Eligible adult hemodialysis (HD) patients (n) *8
9r Eligible adult HD patient-months (n)
*3
9s Kt/V categories among adult HD patients (% of 9r; sums to 100%)
<1.2
5.6
3.6
2.5
1.3
2.7
2.7
2.5
1.2-<1.4
13.3
11.0
8.8
9.4
19.2
19.5
17.2
1.4-<1.6
26.8
26.0
23.0
21.1
29.7
29.6
29.6
1.6-<1.8
26.9
28.6
27.1
29.1
24.4
24.3
25.5
>= 1.8
26.9
30.6
38.6
38.9
22.4
22.2
23.1
0.5
0.2
0.0
0.2
1.7
1.8
2.0
Missing/Out of range/Not performed/Expired
(continued)
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
---
Produced by The University of Michigan Kidney Epidemiology and Cost Center (July 2016)
14/22
Dialysis Facility Report for FY (FY) 2017
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE
TABLE 9: Dialysis Adequacy *1 , May 2012-2015
Measure Name
2012
2013
2014
- State *2 Network *2
2015
U.S. *2
2015
9t Adult HD: Kt/V >=1.2 (% of 9r) *5
94.0
96.3
97.5
98.5
95.6
95.5
95.4
25
31
35
32
7.1
7.4
6.1
245
249
290
248
57.4
60.1
46.6
<1.7
1.6
2.8
3.8
2.4
6.9
6.9
7.5
1.7-<1.9
4.1
6.4
5.2
4.8
19.6
19.2
18.6
1.9-<2.2
8.6
5.6
5.2
6.9
28.6
28.2
28.2
2.2-<2.5
5.3
2.0
1.7
4.0
16.9
16.5
17.5
9u Eligible adult peritoneal dialysis (PD) patients (n)
9v Eligible adult PD patient-months (n) *3
9w Kt/V categories among adult PD patients (% of 9v; sums to 100%)
Missing/Out of range/Not performed/Expired
9x Adult PD: Kt/V >=1.7 (% of 9v) *9
2.0
2.8
4.5
4.8
22.5
22.5
23.1
78.4
80.3
79.7
77.0
5.4
6.7
5.1
20.0
16.9
16.6
20.6
87.7
86.4
87.4
e
>=2.5
Sa
m
pl
n/a = not applicable.
[*1] See Guide, Section XII.
[*2] Values are shown for the average facility.
[*3] Patients may be counted up to 12 times per year.
[*4] Based on in-range values; see Guide for range values.
[*5] HD Kt/V summaries are restricted to patients who dialyze thrice weekly.
[*6] The PD Adequacy section uses the most recent value over a 4-month look-back period. Therefore, reporting for PD in this table begins with August 2012 which includes a look-back through May 2012.
[*7] Kt/V: K = dialyzer clearance of urea; t = dialysis time; V = patient’s total body water. Based on the value code D5: Result of last Kt/V.
[*8] Patient-months reporting 2 or fewer, or 4 or more adult dialysis sessions per week were excluded from the HD Kt/V calculations.
[*9] Values calculated based only on Kt/V values reported in range.
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
---
Produced by The University of Michigan Kidney Epidemiology and Cost Center (July 2016)
15/22
Dialysis Facility Report for FY (FY) 2017
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE
TABLE 10: Mineral Metabolism *1 , May 2012-2015
Measure Name
2012
2013
2014
2015
- State *2 Network *2
U.S. *2
2015
10a Eligible patients (n) *3
176
183
185
176
122.4
134.5
86.4
1184
1784
1765
1733
1113.8
1228.0
760.2
5.7
5.6
5.5
5.6
5.2
5.2
5.3
8.5
11.0
10.2
9.5
8.7
9.1
8.7
3.5-4.5 mg/dL
15.2
17.2
18.7
16.7
24.8
25.2
24.3
4.6-5.5 mg/dL
26.4
24.7
26.6
25.7
28.5
28.7
27.8
5.6-7.0 mg/dL
22.6
23.0
21.0
23.9
19.1
18.8
21.0
>7.0 mg/dL
21.1
18.4
17.3
17.9
10.7
10.4
11.8
6.2
5.6
6.2
6.2
8.2
7.8
6.3
8.7
8.8
9.0
8.8
9.0
9.0
9.0
<8.4 mg/dL
23.8
20.2
18.1
18.9
14.7
14.7
16.3
8.4-10.2 mg/dL
65.6
69.9
72.8
72.3
74.3
74.6
74.0
4.4
4.4
2.9
2.3
2.9
3.0
3.2
6.2
5.4
6.2
6.5
8.2
7.8
6.5
10b Eligible patient-months (n) *4
10c Average phosphorous *5 (mg/dL) (average of 10b)
<3.5 mg/dL
Missing/Out of range
10e Average calcium uncorrected *5 (mg/dL) (average of 10b)
e
10d Phosphorous categories (% of 10b; sums to 100%)
>10.2 mg/dL
Missing/Out of range
pl
10f Calcium uncorrected categories (% of 10b; sums to 100%)
Sa
m
[*1] See Guide, Section XIII.
[*2] Values are shown for the average facility.
[*3] Includes those who switch between HD and PD during the month and patients for whom modality is unknown.
[*4] Patients may be counted up to 12 times per year.
[*5] Based on in-range values; see Guide for range values.
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
---
Produced by The University of Michigan Kidney Epidemiology and Cost Center (July 2016)
16/22
Dialysis Facility Report for FY (FY) 2017
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE
TABLE 11: Vascular Access Information and Access-Releated Infection *1 , 2012-2015
Measure Name
Vascular Access
2012
2013
2014
- State *2 Network *2
2015
*3
U.S. *2
2015
*4
11a Prevalent adult hemodialysis patient-months (n)
948
1389
1331
1307
1035.1
1160.7
730.6
Arteriovenous fistula
51.6
52.1
53.7
57.5
68.7
69.1
65.6
Arteriovenous graft
21.7
22.0
19.2
16.2
16.6
16.3
18.7
Catheter
26.7
25.8
27.1
26.2
14.6
14.6
15.7
0.0
0.0
0.0
0.0
0.0
0.0
0.0
11c Arteriovenous fistulae in place (% of 11a) *5
51.6
52.1
53.9
58.0
69.6
70.1
66.9
11d Catheter only >= 90 days (% of 11a) *6
24.6
22.5
23.8
21.0
9.6
9.6
9.9
11b Vascular access type in use (% of 11a; sums to 100%)
Other/Missing
*3
14
21
16
19
22.7
24.5
17.4
Arteriovenous fistula
7.1
23.8
6.3
5.3
21.6
19.5
19.6
Arteriovenous graft
7.1
0.0
0.0
0.0
4.8
4.0
4.5
11f Vascular access type in use (% of 11e; sums to 100%)
Catheter
Other/Missing
11g Arteriovenous fistulae in place (% of 11e)
Infection: Peritoneal dialysis (PD)
*5
*3
11h Eligible PD patients (n)
85.7
76.2
93.8
94.7
73.5
76.5
75.8
0.0
0.0
0.0
0.0
0.0
0.1
0.1
7.1
23.8
6.3
5.3
23.4
21.4
22.3
30
40
37
34
9.3
9.6
7.4
282
292
324
284
66.5
69.4
53.3
2.48
4.45
8.95
8.45
2.24
2.27
2.49
0.356
0.113
<0.01
<0.01
n/a
n/a
n/a
Sa
m
11i Eligible PD patient-months *4
pl
11e Incident adult hemodialysis patients (n)
e
Vascular Access at First Treatment
11j PD catheter infection rate per 100 PD patient-months *7
11k P-value *8 for 11n (compared to U.S. value) *9
n/a = not applicable
[*1] See Guide, Section XIV.
[*2] Values are shown for the average facility.
[*3] Vascular Access type is based on data reported in CROWNWeb as of May, 2012 so summaries for 2012 are not for a full calendar year. PD infection summaries are based on Medicare Dialysis claims.
[*4] Patients may be counted up to 12 times per year per facility.
[*5] Includes all patients with fistulae, regardless of whether or not they received their hemodialysis treatments using their fistulae.
[*6] Catheter was used for treatment and has been in place for 90 days or more prior to treatment. Patient does not have an fistula or graft in place. Catheter is only access. Port access devices are reported as catheters for this project.
[*7] The ICD-9 PD catheter infection code for PD patients is 996.68 which is effective from 5/1/2012-9/30/2015 and the ICD-10 PD catheter infection code for PD patients is T8571XA which is effective from 10/1/2015-12/31/2015.
[*8] A p-value greater than or equal to 0.05 indicates the differences between the percent of patients with infection at the facility and national percentage is plausibly due to random chance.
[*9] Compared to U.S. value for that year: 3.09 (2012), 3.05 (2013), 2.84 (2014), and 2.49 (2015).
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
---
Produced by The University of Michigan Kidney Epidemiology and Cost Center (July 2016)
17/22
Dialysis Facility Report for FY (FY) 2017
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE
TABLE 12: Comorbidities Reported on Medicare Claims for Medicare Dialysis Patients Treated as of December 31st of
Each Year *1 , 2012-2015
Measure Name
2012
2013
2014
2015
- State *2 Network *2
U.S. *2
2015
12a Medicare dialysis patients on 12/31 (n)
120
118
111
107
62.4
68.0
50.1
0.0
0.0
0.0
0.0
0.9
0.9
1.8
15.8
16.9
10.8
11.2
8.9
9.2
10.5
12b Comorbidity (% yes of 12a)
Infections
AIDS/HIV positive
Dialysis access-related
1.7
3.4
2.7
2.8
1.9
2.0
1.9
Hepatitis other
7.5
11.0
8.1
9.3
5.1
4.8
5.8
Metastatic
5.8
4.2
2.7
2.8
3.0
2.9
3.6
Pneumonia
3.3
3.4
3.6
2.8
6.2
6.3
5.9
Tuberculosis
0.8
0.8
0.0
4.7
0.6
0.7
0.5
40.8
39.8
45.0
43.9
43.4
43.6
45.0
e
Hepatitis B
Other
Cardiovascular
1.4
1.6
35.8
3.3
27.1
19.8
26.2
34.6
34.3
36.7
18.3
19.5
20.7
24.3
22.4
22.4
24.0
47.5
45.8
45.9
50.5
48.0
48.2
51.2
39.2
34.7
35.1
44.9
45.5
45.5
48.6
6.7
7.6
8.1
8.4
8.9
8.9
9.0
37.5
40.7
44.1
42.1
42.9
43.2
42.0
Alcohol dependence
1.7
3.4
4.5
2.8
3.2
3.2
3.1
Anemia
5.0
3.4
1.8
4.7
8.4
9.4
9.1
Cancer
10.0
6.8
8.1
9.3
9.2
9.1
10.8
Chronic obstructive pulmonary disease
22.5
21.2
25.2
23.4
26.4
25.4
32.1
Diabetes
50.0
50.0
53.2
55.1
68.8
70.1
65.9
Drug dependence
2.5
4.2
8.1
11.2
2.8
2.7
2.9
Gastrointestinal tract bleeding
2.5
4.2
1.8
0.0
3.1
3.2
3.4
90.8
94.1
91.9
95.3
87.9
86.4
88.1
4.5
4.5
4.4
4.8
4.8
4.8
5.0
Cardiac dysrhythmia
Cerebrovascular disease
Congestive heart failure
Ischemic heart disease
Myocardial infarction
Sa
m
Peripheral vascular disease
*3
3.4
2.7
1.9
1.4
pl
Cardiac arrest
Other
Hyperparathyroidism
12c Average number of comorbid conditions
n/a = not applicable
[*1] Based on patients with Medicare as primary insurer on 12/31 each year. See Guide, Section XV.
[*2] Values are shown for the average facility.
[*3] Peripheral vascular disease includes venous, arterial and nonspecific peripheral vascular diseases.
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
---
Produced by The University of Michigan Kidney Epidemiology and Cost Center (July 2016)
18/22
Dialysis Facility Report for FY (FY) 2017
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE
TABLE 13: Facility Information *1 , 2015
Measure Name
2015
13a Organization
SAMPLE MEDICAL CARE(SMC)
13b Ownership
Non-profit
13c Initial Medicare certification date
01/01/1999
13d Number of stations
20
13e Services provided
Hemodialysis and Peritoneal Dialysis
13f Shifts after 5:00 pm
- State *2 Network *2
U.S. *2
Yes
13g Dialyzer Reuse
13h CMS Certification Number (CCN) included in this report
13i National Provider Identifier (NPI) *3
999999
1234567890
Patient Placement
2015
13l Transferred out of facility (% of 13j)
13m Patients treated on 12/31 (n)
*4
13n Medicare eligibility status (% of 13m; sums to 100% )
Medicare
Medicare application pending
Non-Medicare
Survey and Certfication
13p Type of survey
164.1
104.9
4.7
12.9
13.1
15.1
5.2
13.4
13.9
14.9
170
108.0
119.0
72.7
50.5
63.6
65.3
59.3
14.7
1.4
1.4
0.9
20.0
39.2
48.0
35.5
04/03/2015
n/a
n/a
n/a
n/a
n/a
n/a
Sa
m
13o Date of last survey
148.9
e
13k Transferred into facility (% of 13j)
212
pl
13j Patients treated during year from AFS Form-2744 (n)
Recertification
13q Compliance condition after survey
Unknown
13r Number of CFC deficiencies cited
2
0.6
0.6
0.3
13s Number of Standard deficiencies cited
11
9.6
11.0
5.9
n/a = not applicable
[*1] See Guide, Section XVI. Information based on data reported in CROWNWeb as of May, 2016. If missing, data were not available.
[*2] Values are shown for the average facility.
[*3] Information based on CROWNWeb data as of March 2016. If missing, data were not available.
[*4] Values may not sum to exactly 100% because of unknown Medicare status.
[*5] Data on this section are from the facility's latest survey since January 2009. If your facility has not been surveyed since January 2009, facility-level data on this table will be missing.
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
---
Produced by The University of Michigan Kidney Epidemiology and Cost Center (July 2016)
19/22
Dialysis Facility Report for FY (FY) 2017
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE
TABLE 14: Selected Measures for Dialysis Patients under Age 18 *1 , 2012-2015
Measure Name
2012
2013
2014
- State *2 Network *2
2015
U.S. *2
Patient Characteristics
14.1a Patients treated on 12/31 (n)
8
3
2
11
n/a
n/a
n/a
<5
12.5
5-9
12.5
66.7
0.0
54.5
35.9
39.2
27.6
0.0
50.0
18.2
12.0
13.1
15.2
10-14
37.5
33.3
50.0
27.3
21.2
20.0
22.8
15-17
37.5
0.0
0.0
0.0
31.0
27.7
34.4
62.5
33.3
50.0
45.5
48.9
49.2
45.1
12.5
0.0
0.0
9.1
7.6
6.9
27.5
0.0
0.0
0.0
0.0
7.1
3.1
4.1
14.1c Age (% of 14.1a; sums to 100%)
14.1d Female (% of 14.1a)
Asian/Pacific Islander
Native American
White
Other/Unknown/Missing
14.1f Ethnicity (% of 14.1a; sums to 100%)
Hispanic
Non-Hispanic
Unknown
14.1g Cause of ESRD (% of 14.1a; sums to 100%)
0.0
0.0
0.0
0.5
0.0
0.8
100
100
90.9
82.1
87.7
65.9
0.0
0.0
0.0
0.0
2.7
2.3
1.8
50.0
33.3
50.0
72.7
58.2
62.3
32.1
50.0
66.7
50.0
27.3
40.2
36.2
67.1
0.0
0.0
0.0
0.0
1.6
1.5
0.8
0.0
0.0
0.0
0.0
5.4
6.9
1.8
0.0
0.0
0.0
0.0
3.3
4.6
2.3
Glomerulonephritis
25.0
0.0
50.0
36.4
23.4
20.8
27.7
Cystic Kidney
12.5
33.3
0.0
9.1
6.5
5.4
5.1
Congenital/Hereditary
37.5
33.3
0.0
45.5
31.0
30.8
42.8
0.0
0.0
0.0
0.0
0.0
0.0
0.0
25.0
33.3
50.0
0.0
19.6
19.2
12.6
0.0
0.0
0.0
9.1
8.7
9.2
5.6
<1
37.5
33.3
0.0
45.5
29.9
23.8
29.7
1-2
12.5
66.7
50.0
27.3
18.5
17.7
21.8
2-3
12.5
0.0
50.0
9.1
15.2
16.9
14.4
3-6
12.5
0.0
0.0
9.1
19.0
22.3
15.9
6+
25.0
0.0
0.0
9.1
17.4
19.2
18.2
In-center hemodialysis
0.0
0.0
0.0
0.0
45.7
47.7
49.5
Home hemodialysis
0.0
0.0
0.0
0.0
0.5
0.8
0.8
Sa
m
Diabetes
0.0
87.5
pl
African American
e
14.1e Race (% of 14.11a; sums to 100%) *3
Hypertension
Hemolytic Uremic Syndrome
Other
Unknown/Missing
14.1i Years since start of ESRD (% of 14.1a; sums to 100%)
14.1k Modality (% of 14.1a; sums to 100%)
Continuous ambulatory peritoneal dialysis
0.0
0.0
0.0
0.0
2.7
0.8
1.5
Continuous cycling peritoneal dialysis
87.5
100
100
100
51.1
50.8
47.8
Other modality *4
12.5
0.0
0.0
0.0
0.0
0.0
0.4
(continued)
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
---
Produced by The University of Michigan Kidney Epidemiology and Cost Center (July 2016)
20/22
Dialysis Facility Report for FY (FY) 2017
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE
TABLE 14 (cont.): Selected Measures for Dialysis Patients under Age 18 *1 , 2012-2015
Measure Name
2012
2013
2014
- State *2 Network *2
2015
U.S. *2
Characteristics of New Dialysis Patients
14.2a Total number of patients with forms (n)
3
2
4
9
n/a
n/a
n/a
14.2g Medical coverage (% of 14.2a; sums to 100%)
Employer group only
0.0
0.0
50.0
11.1
17.2
15.1
18.1
Medicare (alone or combined w/ other insurance)
0.0
50.0
0.0
0.0
35.3
37.0
19.9
Medicaid only
0.0
50.0
0.0
11.1
22.4
15.1
45.6
Other/Unknown/None
100
0.0
50.0
77.8
25.0
32.9
16.5
0
0
0
0
n/a
n/a
n/a
Arteriovenous fistula
.
.
.
.
7.0
8.2
6.9
Arteriovenous graft
.
.
.
.
0.0
0.0
0.9
.
.
.
.
91.5
91.8
91.4
.
.
.
.
1.4
0.0
0.7
.
.
.
.
8.5
10.2
13.2
14.2k Number of incident hemodialysis patients (n)
Catheter
Other/Unknown/Missing
14.2m Arteriovenous fistulae placed (% of 14.2k)
No
pl
14.2s Pre-ESRD nephrologist care (% of 14.2a; sums to 100%)
e
14.2l Access used at first outpatient dialysis (% of 14.2k; sums to 100%)
33.3
50.0
0.0
88.9
23.3
24.7
20.9
33.3
0.0
75.0
11.1
16.4
11.0
17.1
33.3
50.0
0.0
0.0
19.0
16.4
18.1
0.0
0.0
25.0
0.0
27.6
28.8
37.8
0.0
0.0
0.0
0.0
13.8
19.2
6.1
100
100
100
100
82.8
79.5
86.2
14.3a Patients (n=number)
13
11
4
14
n/a
n/a
n/a
14.3b Patient years (PY) at risk (n)
7.2
4.6
2.7
7.3
n/a
n/a
n/a
0
1
0
0
n/a
n/a
n/a
2
5
2
2
n/a
n/a
n/a
14.4b Patient years (PY) at risk (n)
2.0
1.2
1.7
1.4
n/a
n/a
n/a
14.4c Total days hospitalized (n)
13
49
129
0
n/a
n/a
n/a
4
2
6
0
n/a
n/a
n/a
Yes, < 6 months
Yes, 6-12 months
Yes, > 12 months
Unknown
Sa
m
14.2t Informed of transplant options (% of 14.2a)
Death Rates
14.3c Deaths (n)
Days Hospitalized Statistics
14.4a Medicare dialysis patients (n)
Admission Statistics
14.4i Total admissions (n)
Transplantation
14.5d Eligible patients (n)
10
8
4
13
n/a
n/a
n/a
14.5e Patient years (PY) at risk (n)
4.8
3.4
2.7
7.1
n/a
n/a
n/a
1
2
1
1
n/a
n/a
n/a
7
4
6
15
n/a
n/a
n/a
14.5f First transplants (n) *5
Waitlist
14.6a Eligible patients on 12/31 (n)
14.6b Patients on the waitlist (% of 14.6a)
71.4
0.0
33.3
20.0
55.3
49.0
41.1
*6
0.058
0.147
0.534
0.076
n/a
n/a
n/a
Age < 10
0.0
.
33.3
9.1
56.1
50.0
42.0
Age 10-17
100
.
33.3
50.0
64.2
59.7
50.4
14.6c P-value (compared to U.S. value)
14.6d Patients on the waitlist by age (%)
(continued)
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
---
Produced by The University of Michigan Kidney Epidemiology and Cost Center (July 2016)
21/22
Dialysis Facility Report for FY (FY) 2017
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE
TABLE 14 (cont.): Selected Measures for Dialysis Patients under Age 18 *1 ,2012-2015
Measure Name
2012
2013
2014
- State *2 Network *2
2015
U.S. *2
Hemoglobin
14.8a Eligible patients (n) *7
7
9
5
14
n/a
n/a
n/a
43
43
29
85
n/a
n/a
n/a
11.6
11.8
11.7
10.4
11.1
11.0
10.8
9.3
7.0
6.9
37.6
15.8
18.0
22.2
10-<11 g/dL
23.3
20.9
13.8
25.9
21.5
22.5
22.8
11-12 g/dL
32.6
32.6
37.9
15.3
21.0
21.4
24.1
> 12 g/dL
30.2
39.5
31.0
17.6
22.0
20.7
17.1
4.7
0.0
10.3
3.5
19.6
17.4
13.9
14.8b Eligible patient-months (n) *8
14.8c Average hemoglobin *8 (g/dL) (average of 14.8b)
< 10 g/dL
Missing/Out of Range
Kt/V
*11
e
14.8d Hemoglobin categories (% of 14.8b; sums to 100%)
0
0
0
0
n/a
n/a
n/a
14.9.h Eligible HD patient-months (n) *8 *10
.
.
.
.
n/a
n/a
n/a
.
.
.
.
82.4
79.8
88.9
14.9.j HD: Kt/V >= 1.2 (% of 149.r)
14.9.k Eligible peritoneal dialysis (PD) patients (n) *11
14.9.l Eligible PD patient-months (n)
14.9.n PD: Kt/V >= 1.8 (% of 149.v)
*8 *11
pl
14.9.g Eligible hemodialysis (HD) patients (n) *10
6
9
5
14
n/a
n/a
n/a
16
43
29
85
n/a
n/a
n/a
75.0
76.7
86.2
67.1
29.5
30.5
56.1
Sa
m
n/a = not applicable
[*1] See Guide, Section XVII corresponding to the parent table in the DFR.
[*2] Values are shown for the average facility, annualized.
[*3] Sum of all 4 years (all patients) used for calculations; should not be compared to regional averages.
[*4] 'Asian' includes Indian sub-continent. 'Native American' includes Alaskan Native. 'White' includes Middle Eastern and Arabian.
[*5] Other modality includes other dialysis, uncertain modality, and patients not on dialysis but still temporarily assigned to the facility (discontinued dialysis, recovered renal function, and lost to follow-up).
[*6] Among first transplants that occurred after the start of dialysis from 2012-2015, 3.8% of transplants in the U.S. were not included because the transplant occurred fewer than 90 days after the start of ESRD and 1.1% were not
included because the patient was not assigned to a facility at time of transplant.
[*7] Facility waitlist percentage is compared to the U.S. waitlist percentage among pediatric patients for that year: 35.5% (2012), 38.0% (2013), 40.5% (2014), 41.1% (2015). A p-value greater than or equal to 0.05 indicates that the
difference between percent of patients waitlisted at the facility and national percentage is plausibly due to random chance.
[*8] Includes patients who switch between HD and PD during the year and patients for whom modality is unknown.
[*9] Patients may be counted up to 12 times per year.
[*10] Based on in-range values; see Guide for range values.
[*11] Based on the value code D5: result of last Kt/V (K-dialyzer clearance of urea; t-dialysis time; V-patient’s total body water). Values calculated based only on Kt/V values reported in range.
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
---
Produced by The University of Michigan Kidney Epidemiology and Cost Center (July 2016)
22/22